Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Materials
/
AlzChem Group
ACT
AlzChem Group
Rising Global Protein Demand Will Fuel Sustainable Specialty Chemicals
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
23 Jul 25
Updated
15 Aug 25
1
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€185.00
19.7% undervalued
intrinsic discount
15 Aug
€148.60
Loading
1Y
185.8%
7D
-0.4%
Author's Valuation
€185.0
19.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€185.0
19.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
882m
2014
2017
2020
2023
2025
2026
2028
Revenue €881.6m
Earnings €126.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.98%
Chemicals revenue growth rate
0.36%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.22%
Calculation
€126.81m
Earnings '28
x
16.81x
PE Ratio '28
=
€2.13b
Market Cap '28
€2.13b
Market Cap '28
/
9.89m
No. shares '28
=
€215.49
Share Price '28
€215.49
Share Price '28
Discounted to 2025 @ 5.22% p.a.
=
€184.99
Fair Value '25